The future of wound therapy: testing of medical cold plasma brings new hope for patients with chronic wounds

The three leading companies neoplas med GmbH, terraplasma-medical GmbH and Cinogy System GmbH are forming a consortium to commission the trial study in the method evaluation procedure of the Federal Joint Committee (G-BA).

Continue ReadingThe future of wound therapy: testing of medical cold plasma brings new hope for patients with chronic wounds

Innovative partnership for advanced wound care: Wundgruppe24 and Viromed Medical GmbH enter into sales cooperation

Illingen, Garching and Pinneberg, 18.08.2023 - Wundgruppe24 (WG24 GmbH) and Viromed Medical GmbH are delighted to announce their strategic partnership. The cooperation has the clear goal of continuously expanding the…

Continue ReadingInnovative partnership for advanced wound care: Wundgruppe24 and Viromed Medical GmbH enter into sales cooperation
Read more about the article Wound treatment with cold plasma clears the main hurdle on the way to reimbursement by the statutory health insurance funds
Gemeinsamer Bundesausschuss (G-BA)

Wound treatment with cold plasma clears the main hurdle on the way to reimbursement by the statutory health insurance funds

The next step towards reimbursement for cold plasma therapy has been achieved. The Federal Joint Committee decides to conduct a trial study.

Continue ReadingWound treatment with cold plasma clears the main hurdle on the way to reimbursement by the statutory health insurance funds